|
|
||||||||
RI-Mediated Signaling Using a Detailed Mathematical Model1




* Theoretical Biology and Biophysics Group and
Theoretical Chemistry and Molecular Physics Group, Theoretical Division, Los Alamos National Laboratory, Los Alamos, NM 87545;
Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892; and
Department of Mathematics and Statistics, University of New Mexico, Albuquerque, NM 87131
Aggregation of Fc
RI on mast cells and basophils leads to autophosphorylation and increased activity of the cytosolic protein tyrosine kinase Syk. We investigated the roles of the Src kinase Lyn, the immunoreceptor tyrosine-based activation motifs (ITAMs) on the
and
subunits of Fc
RI, and Syk itself in the activation of Syk. Our approach was to build a detailed mathematical model of reactions involving Fc
RI, Lyn, Syk, and a bivalent ligand that aggregates Fc
RI. We applied the model to experiments in which covalently cross-linked IgE dimers stimulate rat basophilic leukemia cells. The model makes it possible to test the consistency of mechanistic assumptions with data that alone provide limited mechanistic insight. For example, the model helps sort out mechanisms that jointly control dephosphorylation of receptor subunits. In addition, interpreted in the context of the model, experimentally observed differences between the
- and
-chains with respect to levels of phosphorylation and rates of dephosphorylation indicate that most cellular Syk, but only a small fraction of Lyn, is available to interact with receptors. We also show that although the
ITAM acts to amplify signaling in experimental systems where its role has been investigated, there are conditions under which the
ITAM will act as an inhibitor.
This article has been cited by other articles:
![]() |
D. Barua, J. R. Faeder, and J. M. Haugh Structure-Based Kinetic Models of Modular Signaling Protein Function: Focus on Shp2 Biophys. J., April 1, 2007; 92(7): 2290 - 2300. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Torigoe, J. R. Faeder, J. M. Oliver, and B. Goldstein Kinetic Proofreading of Ligand-Fc{epsilon}RI Interactions May Persist beyond LAT Phosphorylation J. Immunol., March 15, 2007; 178(6): 3530 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wedagedera and N. J. Burroughs T-Cell Activation: A Queuing Theory Analysis at Low Agonist Density Biophys. J., September 1, 2006; 91(5): 1604 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Hlavacek, J. R. Faeder, M. L. Blinov, R. G. Posner, M. Hucka, and W. Fontana Rules for Modeling Signal-Transduction Systems Sci. Signal., July 18, 2006; 2006(344): re6 - re6. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shankaran, H. S. Wiley, and H. Resat Modeling the Effects of HER/ErbB1-3 Coexpression on Receptor Dimerization and Biological Response Biophys. J., June 1, 2006; 90(11): 3993 - 4009. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Vonakis, S. P. Gibbons Jr, M. J. Rotte, E. A. Brothers, S. C. Kim, K. Chichester, and S. M. MacDonald Regulation of Rat Basophilic Leukemia-2H3 Mast Cell Secretion by a Constitutive Lyn Kinase Interaction with the High Affinity IgE Receptor (Fc{epsilon}RI) J. Immunol., October 1, 2005; 175(7): 4543 - 4554. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Borisov, N. I. Markevich, J. B. Hoek, and B. N. Kholodenko Signaling through Receptors and Scaffolds: Independent Interactions Reduce Combinatorial Complexity Biophys. J., August 1, 2005; 89(2): 951 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Choi, T. Hiragun, J. H. Lee, Y. M. Kim, H.-P. Kim, A. Chahdi, E. Her, J. W. Han, and M. A. Beaven Activation of RBL-2H3 Mast Cells Is Dependent on Tyrosine Phosphorylation of Phospholipase D2 by Fyn and Fgr Mol. Cell. Biol., August 15, 2004; 24(16): 6980 - 6992. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. M. Andrade, T. Hiragun, and M. A. Beaven Dexamethasone Suppresses Antigen-Induced Activation of Phosphatidylinositol 3-Kinase and Downstream Responses in Mast Cells J. Immunol., June 15, 2004; 172(12): 7254 - 7262. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |